The stock of Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) is a huge mover today! The stock decreased 6.40% or $0.27 during the last trading session, reaching $3.95. Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) has risen 22.07% since November 16, 2018 and is uptrending. Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer primarily in the United States. The Company’s therapeutic oncology candidates also comprise MM-310 for treating solid tumors; and MM-151 that has completed a Phase I clinical trial for treating solid tumors.

Source: Wall Street Journal November 16, 2019 19:52 UTC